PrEP for HIV prevention: emtricitabine with tenofovir disoproxil fumarate
Emtricitabine with tenofovir disoproxil fumarate available for pre-exposure prophylaxis (PrEP) for prevention of HIV infection for people who meet the funding criteria.
This means about 4,000 people in New Zealand will be able to access PrEP.
On this page:
The NZ AIDS Foundation has information about PrEP on their websites:
How do I know if I’m eligible to be prescribed funded PrEP?
Funded PrEP is available for people at high risk of contracting HIV, such as men having sex with men (MSM) or transgender people. Talk to your health care professional to discuss whether you meet the criteria. You will have to undergo some tests including for renal function and a range of STIs.
What else can I do to prevent an HIV infection?
Condoms are the main way for everyone to prevent an HIV infection.
Condoms are fully funded on prescription, are highly effective, and reduce the chance of most sexually-transmitted infections being passed from one person to another.
Who is eligible for PrEP?
Check the Special Authority form for the criteria your patient must meet. You can find the latest SA form in the Schedule listing.
Who is eligible to prescribe PrEP?
Any relevant practitioner can prescribe PrEP for HIV prevention.
How can I learn about prescribing PrEP?
The Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) provide online training courses. This training will equip you to renew PrEP applications for your patients.
Where can I find more information about PrEP?
The NZ AIDS Foundation website has good information if you are currently prescribing or considering prescribing PrEP, including helpful guidelines, learning modules and resources.
If you have any questions about funded PrEP, you can contact PHARMAC:
- 0800 660 050 or
Last updated: 26 March 2020